Explore the words cloud of the PHAGO project. It provides you a very rough idea of what is the project "PHAGO" about.
The following table provides information about the project.
Coordinator |
UNIVERSITATSKLINIKUM BONN
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | https://www.phago.eu/ |
Total cost | 18˙088˙176 € |
EC max contribution | 8˙838˙000 € (49%) |
Programme |
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2)) |
Code Call | H2020-JTI-IMI2-2015-05-two-stage |
Funding Scheme | IMI2-RIA |
Starting year | 2016 |
Duration (year-month-day) | from 2016-11-01 to 2021-10-31 |
Take a look of project's partnership.
Alzheimer’s disease (AD) is an age-related chronic neurodegenerative disease with four main pathological changes in the brain: amyloid plaques, fibrillary tau tangles, inflammation and neuronal loss. Phagocytes around amyloid plaques in late onset AD (LOAD) may be neurotoxic but have limited motility and phagocytic activity, suggesting a dysfunctional activation. These phagocytes express the innate immune receptor TREM2 and CD33. Variants of both genes have been linked to LOAD. The main objectives of PHAGO are to find means of modulating microglia/macrophage activation via TREM2, CD33 and related signalling pathways, and determine the effects of such modulation on microglia/macrophage function, amyloid-β and neurodegeneration, in order to find a treatment for AD. PHAGO will deliver well characterized tools and knowledge through which to manipulate AD risk and provide targets and markers ready to progress to drug development. PHAGO will realise this goal by comprehensively attacking the problem simultaneously at multiple levels, including the molecular structures of the receptors, receptor ligand interactions, ectodomain function in vitro and in vivo, characterisation of receptor processing, modification and signalling, receptor-regulated signalling pathways, gene expression and phagocyte function in cells and animals, comprehensive analysis of receptor knock-in and knock-out models crossed to two different animal models of AD, and identification of receptor-related biomarkers in AD patients. Innovative approaches of PHAGO will include identification of new AD-risk genes using a TREM2 co-expression network approach, brain imaging of AD patients with TREM2 and CD33 variants, and generation of patient iPSC-derived microglia/macrophages to comprehensively phenotype gene variants. The project will also generate tools, such as ligands, reporter cells and optimised assays, suitable for further development of treatments targeting TREM2 and/or CD33 in AD.
Knowledge of possible disease mechanisms and targets | Documents, reports | 2020-04-08 21:13:17 |
Crystal structure of CD33 generated to ~3 Ã… and refined to ~2 Ã… | Documents, reports | 2020-04-08 21:13:17 |
Determination of the cleavage site | Documents, reports | 2020-04-08 21:13:16 |
A comprehensive roadmap for data and knowledge management for the PHAGO consortium, collection of pre-existing ethical documents | Documents, reports | 2020-04-08 21:13:17 |
Press release containing a common part and a part that can be personalised by every partner | Websites, patent fillings, videos etc. | 2020-04-08 21:13:16 |
Launch of website, Twitter and other dissemination activities | Websites, patent fillings, videos etc. | 2020-04-08 21:13:17 |
Completion of the analysis of changes in the glycosylation of TREM2 ectodomains in the presence of R47H variants | Documents, reports | 2020-04-08 21:13:17 |
CD33 receptor ligands characterization in human primary monocytes | Documents, reports | 2020-04-08 21:13:17 |
Providing existing RNAseq signatures and cytokine/chemokine signatures of microglia from tg4510 (tau) mice at various time points | Demonstrators, pilots, prototypes | 2020-04-08 21:13:17 |
Take a look to the deliverables list in detail: detailed list of PHAGO deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Samira Parhizkar, Thomas Arzberger, Matthias Brendel, Gernot Kleinberger, Maximilian Deussing, Carola Focke, Brigitte Nuscher, Monica Xiong, Alireza Ghasemigharagoz, Natalie Katzmarski, Susanne Krasemann, Stefan F. Lichtenthaler, Stephan A. Müller, Alessio Colombo, Laura Sebastian Monasor, Sabina Tahirovic, Jochen Herms, Michael Willem, Nadine Pettkus, Oleg Butovsky, Peter Bartenstein, Dieter Edb Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE published pages: 191-204, ISSN: 1097-6256, DOI: 10.1038/s41593-018-0296-9 |
Nature Neuroscience 22/2 | 2020-04-08 |
2017 |
Johannes Jungverdorben, Andreas Till, Oliver Brüstle Induced pluripotent stem cell-based modeling of neurodegenerative diseases: a focus on autophagy published pages: 705-718, ISSN: 0946-2716, DOI: 10.1007/s00109-017-1533-5 |
Journal of Molecular Medicine 95/7 | 2020-04-08 |
2019 |
Meliha Karsak, Konstantin Glebov, Marina Scheffold, Thomas Bajaj, Amit Kawalia, Ilker Karaca, Sebastian Rading, Johannes Kornhuber, Oliver Peters, Monica Diezâ€Fairen, Lutz Frölich, Michael Hüll, Jens Wiltfang, Martin Scherer, Steffi Riedelâ€Heller, Anja Schneider, Michael T. Heneka, Klaus Fliessbach, Ahmed Sharaf, Holger Thiele, Martina Lennarz, Frank Jessen, Wolfgang Maier, Christian Kubisch A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2 published pages: , ISSN: 1059-7794, DOI: 10.1002/humu.23904 |
Human Mutation | 2020-04-08 |
2019 |
Antonio Boza-Serrano, RocÃo Ruiz, Raquel Sanchez-Varo, Juan GarcÃa-Revilla, Yiyi Yang, Itzia Jimenez-Ferrer, Agnes Paulus, Malin Wennström, Anna Vilalta, David Allendorf, Jose Carlos Davila, John Stegmayr, Sebastian Jiménez, Maria A. Roca-Ceballos, Victoria Navarro-Garrido, Maria Swanberg, Christine L. Hsieh, Luis M. Real, Elisabet Englund, Sara Linse, Hakon Leffler, Ulf J. Nilsson, Guy C. Bro Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease published pages: 251-273, ISSN: 0001-6322, DOI: 10.1007/s00401-019-02013-z |
Acta Neuropathologica 138/2 | 2020-04-08 |
2019 |
Luke A. Miles, Stefan J. Hermans, Gabriela A.N. Crespi, Jonathan H. Gooi, Larissa Doughty, Tracy L. Nero, Jasmina Markulić, Andreas Ebneth, Berthold Wroblowski, Daniel Oehlrich, Andrés A. Trabanco, Marie-Laure Rives, Ines Royaux, Nancy C. Hancock, Michael W. Parker Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis published pages: 110-118, ISSN: 2589-0042, DOI: 10.1016/j.isci.2019.07.023 |
iScience 19 | 2020-04-08 |
2019 |
Guy C. Brown The endotoxin hypothesis of neurodegeneration published pages: , ISSN: 1742-2094, DOI: 10.1186/s12974-019-1564-7 |
Journal of Neuroinflammation 16/1 | 2020-04-08 |
2018 |
Bettina Linnartzâ€Gerlach, Liviuâ€Gabriel Bodea, Christine Klaus, Aurélien Ginolhac, Rashi Halder, Lasse Sinkkonen, Jochen Walter, Marco Colonna, Harald Neumann TREM2 triggers microglial density and ageâ€related neuronal loss published pages: , ISSN: 0894-1491, DOI: 10.1002/glia.23563 |
Glia | 2020-04-08 |
2018 |
A.E. M. Phillips, C. Villegas Llerena, T.M. Piers, K. Cosker, J. Hardy and J. M. Pocock Loss of Function of TREM2 Results in Cytoskeletal Malfunction in Microglia published pages: , ISSN: 2379-7150, DOI: |
Journal of Neurology and Neurobiology Voulme 4 Issue 3 | 2020-04-08 |
2017 |
Peter Thornton, Jean Sevalle, Michael J Deery, Graham Fraser, Ye Zhou, Sara StÃ¥hl, Elske H Franssen, Roger B Dodd, Seema Qamar, Beatriz Gomez Perezâ€Nievas, Louise SC Nicol, Susanna Eketjäll, Jefferson Revell, Clare Jones, Andrew Billinton, Peter H St Georgeâ€Hyslop, Iain Chessell, Damian C Crowther TREM2 shedding by cleavage at the H157â€S158 bond is accelerated for the Alzheimer\'s diseaseâ€associated H157Y variant published pages: 1366-1378, ISSN: 1757-4676, DOI: 10.15252/emmm.201707673 |
EMBO Molecular Medicine 9/10 | 2020-04-08 |
2017 |
Kai Schlepckow, Gernot Kleinberger, Akio Fukumori, Regina Feederle, Stefan F Lichtenthaler, Harald Steiner, Christian Haass An Alzheimerâ€associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function published pages: 1356-1365, ISSN: 1757-4676, DOI: 10.15252/emmm.201707672 |
EMBO Molecular Medicine 9/10 | 2020-04-08 |
2018 |
Guillermo Carbajosa, Karim Malki, Nathan Lawless, Hong Wang, John W. Ryder, Eva Wozniak, Kristie Wood, Charles A. Mein, Richard J.B. Dobson, David A. Collier, Michael J. O\'Neill, Angela K. Hodges, Stephen J. Newhouse Loss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain published pages: 151-166, ISSN: 0197-4580, DOI: 10.1016/j.neurobiolaging.2018.04.019 |
Neurobiology of Aging 69 | 2020-04-08 |
2018 |
Alejandro Carrillo-Jimenez, Mar PuigdellÃvol, Anna Vilalta, Jose Luis Venero, Guy Charles Brown, Peter StGeorge-Hyslop, Miguel Angel Burguillos Effective Knockdown of Gene Expression in Primary Microglia With siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation published pages: , ISSN: 1662-5102, DOI: 10.3389/fncel.2018.00313 |
Frontiers in Cellular Neuroscience 12 | 2020-04-08 |
2018 |
Xianyuan Xiang, Thomas M. Piers, Benedikt Wefers, Kaichuan Zhu, Anna Mallach, Bettina Brunner, Gernot Kleinberger, Wilbur Song, Marco Colonna, Jochen Herms, Wolfgang Wurst, Jennifer M. Pocock, Christian Haass The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans published pages: , ISSN: 1750-1326, DOI: 10.1186/s13024-018-0280-6 |
Molecular Neurodegeneration 13/1 | 2020-04-08 |
2018 |
Pablo Garcia-Reitboeck, Alexandra Phillips, Thomas M. Piers, Claudio Villegas-Llerena, Matt Butler, Anna Mallach, Celia Rodrigues, Charles E. Arber, Amanda Heslegrave, Henrik Zetterberg, Harald Neumann, Stephen Neame, Henry Houlden, John Hardy, Jennifer M. Pocock Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis published pages: 2300-2311, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.07.094 |
Cell Reports 24/9 | 2020-04-08 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PHAGO" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PHAGO" are provided by the European Opendata Portal: CORDIS opendata.
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Read More